Exome Asset Management LLC Bridge Bio Pharma, Inc. Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 165,496 shares of BBIO stock, worth $5.34 Million. This represents 5.09% of its overall portfolio holdings.
Number of Shares
165,496
Previous 246,700
32.92%
Holding current value
$5.34 Million
Previous $6.77 Billion
15.49%
% of portfolio
5.09%
Previous 5.09%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$712 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$621 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$402 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$231 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.78B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...